Vibe Bio and Patient Driven Drug Development

My parents shared the grim news. Our dear friends’ new grandchild was born with a rare disease. The family urgently sought a contact at a pharmaceutical company that had developed a treatment, but had decided not to bring it to market. Our friends were petitioning to have a compassionate use exception granted. In essence, they were begging to save the life of their grandchild.